MEDICAL RESOURCES INC /DE/
8-K, 1999-01-22
MEDICAL LABORATORIES
Previous: CINTAS CORP, 424B3, 1999-01-22
Next: MEDICAL RESOURCES INC /DE/, S-8, 1999-01-22



<PAGE>



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



     Date of Report (Date of earliest event reported): December 21, 1998




                             MEDICAL RESOURCES, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)



       Delaware                    1-12461                     13-3584552
     ------------               -------------                 ------------
   (State of other             (Commission File              (IRS Employer  
    jurisdiction of                Number)                 Identification No.)
    incorporation)


                    



     15 State Street, Hackensack, NJ                        07601
     ----------------------------------------             --------        
     (Address of principal executive offices)             Zip Code




     Registrant's telephone number, including area code: (201) 488-6230
                                                         --------------




<PAGE>



Item 5.

         On December 21, 1998 and January 15, 1999, respectively, Medical
Resources, Inc. (the "Company") announced the settlement of the class action
litigation pending against the Company and the grant of a hearing before the
Nasdaq Qualifications Hearing Panel relating to the Company's request to move
its stock listing from the Nasdaq National Market to the Nasdaq SmallCap Market.
A copy of the press releases issued by the Company in respect of the foregoing
announcements is attached hereto as Exhibit 99.1 and Exhibit 99.2 and
incorporated herein by reference.

Item 7.  Financial Statements and Exhibits

99.1  Press Release, dated December 21, 1998 issued by Medical Resources, Inc.
99.2  Press Release, dated January 15, 1999 issued by Medical Resources, Inc.















<PAGE>



                                   SIGNATURES



         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                          MEDICAL RESOURCES, INC.


Dated:   January 21, 1999                 By:   /s/ Christopher J. Joyce
                                             -----------------------------------
                                          Name:    Christopher J. Joyce
                                          Title:   Senior Vice President - Legal
                                                   Affairs and Administration

















                                        2




<PAGE>




MEDICAL
RESOURCES, INC.

                                  PRESS RELEASE
                                  -------------

            Medical Resources, Inc. Announces Agreement-in-Principle
                        To Settle Class Action Law Suits



HACKENSACK, N.J., Dec. 21 /PRNewswire/ -- Medical Resources, Inc. (Nasdaq: MRII)
today announced that it has reached an  agreement-in-principle  to settle all of
the consolidated  class action lawsuits  currently  pending against the Company.
Under the terms of the  agreement-in-principle,  which is subject to approval by
the federal court in the District of New Jersey at a hearing expected to be held
in late February or in March of 1999,  the  plaintiffs in the class actions will
receive, in full settlement of their claims, $2.75 million in insurance proceeds
and $5.25 million of Convertible Subordinated Notes newly-issued by the Company.

The $5.25 million of  Convertible  Subordinated  Notes will bear interest at the
rate of 8% per annum,  will be due on the  earlier of August 1, 2005 or when the
Company's  presently  outstanding  Senior  Notes  are paid in  full,  and may be
prepaid in cash by the Company at any time after issuance subject to the payment
of  a  prepayment   premium  which  begins  at  8%  and  decreases   over  time.
Additionally, the Convertible Subordinated Notes will be convertible into shares
of the Company's  Common Stock beginning  February 15, 2000 at a price per share
equal to the  greater of $3.00 or 120% of the ten day average  closing  price of
the Company's Common Stock as of the court hearing date.

The  agreement-in-principle and the class action settlement contemplated thereby
are  further  subject  to  (1)  consent  to  the  issuance  of  the  Convertible
Subordinated  Notes by the  Company's  Senior Note  lenders and (2) the right of
either  the  Company  or the  attorneys  representing  the class  plaintiffs  to
terminate the agreement-in-principle if the ten day average closing price of the
Company's  Common  Stock as of the court  hearing  date is less  than  $1.75 per
share.

Medical  Resources  specializes  in the  ownership,  operation and management of
fixed-site  outpatient medical diagnostic imaging centers.  The Company operates
more  than 90  imaging  centers  in the U.S.  and  provides  network  management
services  to  managed  care  organizations  in  regions  where its  centers  are
concentrated.

                                    * * * * *

Note: This release contains forward-looking statements within the meaning of the
Private Securities  Litigation Reform Act of 1995.  Investors are cautioned that
forward-looking  statements are inherently  uncertain.  Actual  performance  and
results may differ materially from





                                       



<PAGE>



that  projected  or  suggested  herein  due to certain  risks and  uncertainties
including,  without  limitation:  the  ability  of the  Company  to  effectively
integrate the operations and information  systems of businesses acquired in 1997
and earlier; the ability of the Company to generate net positive cash flows from
operations;   the  payment  timing  and  ultimate   collectibility  of  accounts
receivable (including purchased accounts receivable) from different payer groups
(including  Personal  Injury type);  the economic  impact of  involuntary  share
repurchases and other payments  (including price protection payments and penalty
payments) caused by the delay in the effectiveness of the Company's Registration
Statement  and by the  decline  in the  Company's  share  price;  the  potential
dilution  that  would  result  from the  conversion  of the  Company's  Series C
Convertible  Preferred  Stock into common shares at current  share  prices;  the
impact of a changing mix of managed care and personal  injury claim  business on
contractual  allowance  provisions,  net revenues and bad debt  provisions;  the
ultimate economic impact of recent litigation  including  shareholder and former
management  lawsuits  against  the Company  and  certain of its  Directors;  the
availability  of debt and/or equity  capital,  on reasonable  terms,  to finance
operations as needed and to finance growth; and the effects of federal and state
laws and regulations on the Company's business over time. Additional information
concerning  certain risks and  uncertainties  that could cause actual results to
differ materially from that projected or suggested is contained in the Company's
filings  with the  Securities  and  Exchange  Commission  (SEC) over the last 12
months,  copies of which are  available  from the SEC or from the  Company  upon
request.



CONTACT:
MEDICAL RESOURCES, INC.
Geoffrey A. Whynot
Senior Vice President - Finance and
Chief Financial Officer
201 883-5460













                                       2




<PAGE>




MEDICAL
RESOURCES, INC.

                                  PRESS RELEASE
                                  -------------


              Medical Resources Granted Hearing Before Nasdaq Panel



Hackensack,  NJ, January 15, 1999 - Medical Resources, Inc. (NASDAQ: MRII) today
announced  that it has been granted a hearing  before the Nasdaq  Qualifications
Hearing Panel  relating to its request to move its stock listing from the Nasdaq
National Market System to the Nasdaq SmallCap Market. The hearing is expected to
occur during the third or fourth week of March,  1999. Until then, the Company's
listing will remain on the Nasdaq National Market System.

The Company  previously  announced  that Nasdaq is  reviewing  it for  continued
listing  on the  National  Market  System  due to its  failure to meet the $5.00
minimum bid price  requirement.  The Company also  previously  announced that it
would  attempt  to move its  listing to the  Nasdaq  SmallCap  Market if it were
unable to meet the  requirements  for continued  listing on the National  Market
System.  Notwithstanding  the foregoing and the grant of a hearing, no assurance
can be given that the Company will be successful in  maintaining  its listing on
the National Market System or in moving its listing to the SmallCap Market.

Medical  Resources  specializes  in the  ownership,  operation and management of
fixed-site  outpatient medical diagnostic imaging centers.  The Company operates
more  than 90  imaging  centers  in the U.S.  and  provides  network  management
services  to  managed  care  organizations  in  regions  where its  centers  are
concentrated.

                                    * * * * *

Note: This release contains forward-looking statements within the meaning of the
Private Securities  Litigation Reform Act of 1995.  Investors are cautioned that
forward-looking  statements are inherently  uncertain.  Actual  performance  and
results may differ  materially  from that  projected or suggested  herein due to
certain risks and uncertainties  including,  without limitation:  the ability of
the Company to effectively  integrate the operations and information  systems of
businesses acquired in 1997 and earlier;  the ability of the Company to generate
net  positive  cash flows  from  operations;  the  payment  timing and  ultimate
collectibility of accounts receivable  (including purchased accounts receivable)
from  different  payer groups  (including  Personal  Injury type);  the economic
impact of involuntary  share  repurchases  and other payments  (including  price
protection   payments  and  penalty   payments)  caused  by  the  delay  in  the
effectiveness of the Company's  Registration Statement and by the decline in the
Company's  share  price;  the  potential  dilution  that would  result  from the
conversion of the Company's Series C



                                       




<PAGE>



Convertible  Preferred  Stock into common shares at current  share  prices;  the
impact of a changing mix of managed care and personal  injury claim  business on
contractual  allowance  provisions,  net revenues and bad debt  provisions;  the
ability  of the  Company  to  meet  all of the  conditions  precedent  to  final
settlement of the class action litigation against the Company and certain of its
Directors  pursuant to the settlement  agreement-in-principle  entered into last
December; the ultimate economic impact of former management lawsuits against the
Company and certain of its  Directors;  the  availability  of debt and/or equity
capital,  on reasonable  terms,  to finance  operations as needed and to finance
growth;  and the  effects  of  federal  and state  laws and  regulations  on the
Company's business over time.  Additional  information  concerning certain risks
and uncertainties that could cause actual results to differ materially from that
projected or suggested is contained in the Company's filings with the Securities
and  Exchange  Commission  (SEC)  over the last 12  months,  copies of which are
available from the SEC or from the Company upon request.



CONTACT:
MEDICAL RESOURCES, INC.
Geoffrey A. Whynot
Senior Vice President - Finance and
Chief Financial Officer
201 883-5460












                                        2





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission